APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,197,712 | -36.1% | 793,841 | +53.1% | 0.49% | -27.7% |
| Q2 2023 | $47,234,895 | -35.4% | 518,495 | -53.3% | 0.67% | -36.5% |
| Q1 2023 | $73,174,837 | +28.2% | 1,109,382 | +0.5% | 1.06% | +40.1% |
| Q4 2022 | $57,099,061 | -17.0% | 1,104,217 | +9.6% | 0.76% | -23.3% |
| Q3 2022 | $68,809,000 | +26.1% | 1,007,444 | -16.5% | 0.99% | +28.1% |
| Q2 2022 | $54,554,000 | -2.3% | 1,206,422 | +9.8% | 0.77% | +19.0% |
| Q1 2022 | $55,825,000 | +81.5% | 1,098,712 | +68.9% | 0.65% | +104.4% |
| Q4 2021 | $30,760,000 | +1844.4% | 650,591 | +1255.4% | 0.32% | +1881.2% |
| Q3 2021 | $1,582,000 | -47.9% | 48,000 | 0.0% | 0.02% | -46.7% |
| Q2 2021 | $3,034,000 | +47.3% | 48,000 | 0.0% | 0.03% | +36.4% |
| Q1 2021 | $2,060,000 | -25.0% | 48,000 | 0.0% | 0.02% | -29.0% |
| Q4 2020 | $2,746,000 | +242.8% | 48,000 | +60.5% | 0.03% | +93.8% |
| Q1 2020 | $801,000 | – | 29,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |